Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies

Lignende værker

• 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
  af: Puttagunta, Sailaja, et al.
  Udgivet: (2014)
• 267 Dalbavancin for the treatment of Streptococcal Skin Infections
  af: Puttagunta, Sailaja, et al.
  Udgivet: (2014)
• Selection of a Surrogate Agent (Vancomycin or Teicoplanin) for Initial Susceptibility Testing of Dalbavancin: Results from an International Antimicrobial Surveillance Program
  af: Jones, Ronald N., et al.
  Udgivet: (2006)
• 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
  af: Puttagunta, Sailaja, et al.
  Udgivet: (2014)
• In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program
  af: McCurdy, Sandra P., et al.
  Udgivet: (2015)